Prestige BioPharma
Manufacturing · Singapore · 11-50 Employees
View Company Info for Free
Overview
Headquarters
20 Biopolis Way #05-01 Biopreneur 5, Sin...Phone Number
+65 65537220Website
www.prestigebiopharma.comRevenue
$5.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
2
1
1
1
1
About Prestige BioPharma
PRESTIGE BIOPHARMA LIMITED is a Singapore-based biopharmaceutical company with operations in USA and Korea, specializing in the discovery and development of biosimilars, novel antibodies and vaccines. Prestige strives to become a global innovator through the development of first-in-class antibody therapeutics including PBP1510 anti-PAUF mAb for pancreatic cancer (INN-Ulenistamab) that recently obtained orphan designation from FDA, EMA and MFDS. Prestige's rich portfolio of biosimilars in various stages including HD201 trastuzumab in EU EMA's MAA review, HD204 bevacizumab in global Phase 3, PBP1502 adalimumab in Phase 1 and others, is aimed to provide affordable quality medicines to those who need. Prestige has expanded its business into development and manufacturing of vaccines through its global scale vaccine center, starting with partnered commercial production of COVID-19 vaccines.Explore more
Prestige BioPharma Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Prestige BioPharma your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Prestige BioPharma had a recent Job posting/layoffs
Earning: See what the market has to say on Prestige BioPharma recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Prestige BioPharma, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Prestige BioPharma has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Prestige BioPharma launches new products
Funding: Get notified immidiatlly once Prestige BioPharma has new funding data
Congratulate Masked Content for being promoted to Masked Content at Prestige BioPharma
Check out if Prestige BioPharma is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined Prestige BioPharma as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Prestige BioPharma is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Prestige BioPharma is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Prestige BioPharma.
Prestige BioPharma Tech Stack
A closer look at the technologies used by Prestige BioPharma
See more technologies
Most Recent Scoops
Project
Product Management, Intellectual Property, Legal Affairs, Logistics / Supply Chain, Pharmaceuticals
Event
Product Marketing, Events, Training, Sales, Logistics / Supply Chain, Pharmaceuticals, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
Event
Product Marketing, Events, Training, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Technology
Event
Product Marketing, Events, Software, Field /Outside Sales, Field Marketing, Healthcare Operations, Healthcare Technology
Prestige BioPharma News & Media
Prestige Biopharma IDC Files Patent for Next-Generation Antibody Delivery Platform 'IDC224'… Driving Innovation in Subcutaneous (SC) Formulations
SEOUL, South Korea, April 23, 2026 /PRNewswire/ -- Prestige Biopharma IDC, the innovative drug research institute of Prestige Biopharma, announced that it has filed a patent for 'IDC224,' a next-generation subcutaneous (SC) delivery platform designed to simultaneously enhance the administration convenience and therapeutic efficacy of antibody therapeutics. While most current antibody therapeutics are administered via intravenous (IV) infusion—typically requiring more than an hour and dedicated mPrestige Biopharma Announces Positive Topline Results from Comparative SAMSON-II Study for HD204, a Potential Biosimilar to Avastin (bevacizumab)
Primary endpoint of Overall Response Rate at Week 18 met, demonstrating clinical equivalence in patients with advanced non-squamous non-small cell lung cancer SINGAPORE, March 24, 2026 /PRNewswire/ -- Prestige Biopharma today announced positive topline results from its Phase 3 SAMSON-II...Prestige Biopharma and Biosidus Enter Exclusive License Agreement for Tuznue® Commercialization in Latin America
SINGAPORE, Nov. 26, 2025 /PRNewswire/ -- Prestige Biopharma, a biopharmaceutical company specializing in antibody therapeutics, today announced an exclusive license and supply agreement with Biosidus, a biotechnology company headquartered in Buenos Aires, Argentina, with decades of experience in biosimilar development and commercialization, for the commercialization of Tuznue® (trastuzumab) across Latin American markets, including Argentina, Mexico, Bolivia, and Paraguay. Tuznue® is a biosimilarTeva and Prestige Biopharma Enter License Agreement for Tuznue® Commercialization in Europe
TEL AVIV, Israel, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals International GmbH, a subsidiary of Teva Pharmaceutical Industries Ltd. (NYSE: and TASE: TEVA) entered into a license agreement with Prestige Biopharma, for the commercialization of Tuznue® (trastuzumab), a biosimilar to Herceptin®, across a majority of European markets.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Prestige BioPharma
Sign Up For FreeTo access detailed company insights
PRESTIGE BIOPHARMA LIMITED is a Singapore-based biopharmaceutical company with operations in USA and Korea, specializing in the discovery and development of biosimilars, novel antibodies and vaccines. Prestige strives to become a global innovator through the development of first-in-class antibody therapeutics including PBP1510 anti-PAUF mAb for pan... Read More
